Skip Nav Destination
Issues
Cancer Research
Table of Contents
Advances in Brief
SKY1 Is Involved in Cisplatin-induced Cell Kill in Saccharomyces cerevisiae, and Inactivation of Its Human Homologue, SRPK1, Induces Cisplatin Resistance in a Human Ovarian Carcinoma Cell Line1
Paul W. Schenk; Antonius W. M. Boersma; Jourica A. Brandsma; Hans den Dulk; Herman Burger; Gerrit Stoter; Jaap Brouwer; Kees Nooter
Identification of a Mononucleotide Repeat as a Major Target for Mitochondrial DNA Alterations in Human Tumors1
Montserrat Sanchez-Cespedes; Paola Parrella; Shuji Nomoto; Daniel Cohen; Yan Xiao; Manel Esteller; Carmen Jeronimo; Richard C. K. Jordan; Theresa Nicol; Wayne M. Koch; Mark Schoenberg; Paola Mazzarelli; Vito M. Fazio; David Sidransky
Biochemistry and Biophysics
Carcinogenesis
Endocrinology
Epidemiology and Prevention
Experimental Therapeutics
Induction of Apoptosis in 9-Nitrocamptothecin-treated DU145 Human Prostate Carcinoma Cells Correlates with de Novo Synthesis of CD95 and CD95 Ligand and Down-Regulation of c-FLIPshort1
Devasis Chatterjee; Ingo Schmitz; Andreas Krueger; Kam Yeung; Sabine Kirchhoff; Peter H. Krammer; Marcus E. Peter; James H. Wyche; Panayotis Pantazis
Potent Antitumor Activity and Improved Pharmacological Profile of ST1481, a Novel 7-substituted Camptothecin1
Michelandrea De Cesare; Graziella Pratesi; Paola Perego; Nives Carenini; Stella Tinelli; Lucio Merlini; Sergio Penco; Claudio Pisano; Federica Bucci; Loredana Vesci; Silvia Pace; Francesca Capocasa; Paolo Carminati; Franco Zunino
The Characterization of Novel, Dual ErbB-2/EGFR, Tyrosine Kinase Inhibitors: Potential Therapy for Cancer
David W. Rusnak; Karen Affleck; Stuart G. Cockerill; Colin Stubberfield; Robert Harris; Martin Page; Kathryn J. Smith; Stephen B. Guntrip; Malcolm C. Carter; Robert J. Shaw; Amanda Jowett; Jeremy Stables; Peter Topley; Edgar R. Wood; Perry S. Brignola; Sue H. Kadwell; Bryan R. Reep; Robert J. Mullin; Krystal J. Alligood; Barry R. Keith; Renae M. Crosby; Doris M. Murray; W. Blaine Knight; Tona M. Gilmer; Karen Lackey
Expression of CD26 and Its Associated Dipeptidyl Peptidase IV Enzyme Activity Enhances Sensitivity to Doxorubicin-induced Cell Cycle Arrest at the G2/M Checkpoint1
Ugur Aytac; Francois-Xavier Claret; Linus Ho; Kazuya Sato; Kei Ohnuma; Gordon B. Mills; Fernando Cabanillas; Chikao Morimoto; Nam H. Dang
Mechanisms of Uptake and Resistance to Troxacitabine, a Novel Deoxycytidine Nucleoside Analogue, in Human Leukemic and Solid Tumor Cell Lines
Henriette Gourdeau; Marilyn L. Clarke; France Ouellet; Delores Mowles; Milada Selner; Annie Richard; Nola Lee; John R. Mackey; James D. Young; Jacques Jolivet; Ronald G. Lafrenière; Carol E. Cass
Immunology
Absence of the Wild-Type Allele Predicts Poor Prognosis in Adult de Novo Acute Myeloid Leukemia with Normal Cytogenetics and the Internal Tandem Duplication of FLT3: A Cancer and Leukemia Group B Study1
Susan P. Whitman; Kellie J. Archer; Lan Feng; Claudia Baldus; Brian Becknell; Brian D. Carlson; Andrew J. Carroll; Krzysztof Mrózek; James W. Vardiman; Stephen L. George; Jonathan E. Kolitz; Richard A. Larson; Clara D. Bloomfield; Michael A. Caligiuri
Molecular Biology and Genetics
Second Primary or Recurrence? Comparative Patterns of p53 and K-ras Mutations Suggest that Serous Borderline Ovarian Tumors and Subsequent Serous Carcinomas Are Unrelated Tumors1
B. Hannah Ortiz; Monica Ailawadi; Cristiano Colitti; Michael G. Muto; Michael Deavers; Elvio G. Silva; Ross S. Berkowitz; Samuel C. Mok; David M. Gershenson
Multipoint Imprinting Analysis Indicates a Common Precursor Cell for Gonadal and Nongonadal Pediatric Germ Cell Tumors1
Dominik T. Schneider; Amy E. Schuster; Michael K. Fritsch; Jie Hu; Thomas Olson; Stephen Lauer; Ulrich Göbel; Elizabeth J. Perlman; the Pediatric Oncology Group; German Pediatric Germ Cell Tumor Study Group
Epigenetic Inactivation of the RASSF1A 3p21.3 Tumor Suppressor Gene in Both Clear Cell and Papillary Renal Cell Carcinoma1
Catherine Morrissey; Alonso Martinez; Malgorzata Zatyka; Angelo Agathanggelou; Sofia Honorio; Dewi Astuti; Neil V. Morgan; Holger Moch; Frances M. Richards; Takeshi Kishida; Masahiro Yao; Peter Schraml; Farida Latif; Eamonn R. Maher
Tumor Biology
Letters to the Editor
Journal Archive
Cancer Research
(1941-Present; volumes 1-current)Published twice monthly since 1987. From 1941-1986, published monthly.
(ISSN 0008-5472)
The American Journal of Cancer
(1931-1940; volumes 15-40)Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.
(ISSN 0099-7374)
The Journal of Cancer Research
(1916-1930); volumes 1-14)Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.
(ISSN 0099-7013)
Advertisement
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds